02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(1995): Vogt T+, Br J Dermatol 133, 994<br />

(1992): Martinez-Frias ML+, Lancet 339, 742<br />

(1985): Milham S, Teratology 32, 321<br />

(1984): Bachrach LK+, Can Med Assoc J 130, 1264<br />

Hypersensitivity<br />

(2006): Ozaki N+, Diabetes Care 29(5), 1179<br />

(2005): Ozaki N+, Thyroid 15(12), 1333<br />

Myalgia/Myositis/Myopathy/Myotoxicity<br />

Polyarteritis nodosa<br />

Scalp defects<br />

(1985): Milham S, Teratology 32, 321<br />

Serum sickness<br />

(1983): Van Kuyk M+, Acta Clin Belg (French) 38, 68<br />

METHOCARBAMOL<br />

Trade names: Carbametin; Carxin; Delaxin; Lumirelax;<br />

Marbaxin; Miowas; Ortoton; Robaxin (Baxter) (Elkins-Sinn);<br />

Robinax; Robomol; Trolar<br />

Indications: Muscle spasm, tetanus<br />

Category: Central muscle relaxant<br />

Half-life: 1–2 hours<br />

Clinically important, potentially hazardous interactions<br />

with: ethanol<br />

Reactions<br />

Skin<br />

Allergic reactions (sic) (1–10%)<br />

Exanthems<br />

Pruritus<br />

Rash (sic)<br />

Urticaria<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

Injection-site pain (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!